QUESTCOR PHARMACEUTICALS INC

Delisted

CIK 891288fmd_165518KC8NYKDG854NW67H7R3RManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Jun 30, 2014, 19 periods

Income Statement · Annual · Millions · USD
Line item	FY2009	FY2010	FY2011	FY2012	FY2013
Total revenues	88	115	218	509	799
Cost of revenue	7	8	12	29	74
Gross profit	81	107	206	481	725
Research and development	10	11	17	34	60
Selling, general and administrative	30	42	74	148	209
Total operating expenses	40	53	93	184	285
Operating income	41	54	113	297	440
Interest and investment income	1	1	1	1	0
Income before taxes	42	54	114	297	440
Income tax expense	16	19	34	100	147
Net income from continuing operations	27	35	80	198	293
Net income	27	35	80	198	293